Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

6 treatments under study, led by Supine Vm Vad

Research Leaders

5 sponsors active, led by Royal Devon and Exeter NHS Foundation Trust

Related Conditions

Often studied with 8 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 37/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Completed2
Active Not Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT07719439Active Not Recruiting

Heart Rate Variability and Early Cytokine Profile in Pediatric Adenotonsillectomy

NCT03298880Not ApplicableCompleted

Testing of a Valsalva Assist Device (VAD) in Healthy Volunteers Performing a Valsalva Manoeuvre

NCT03514628Not ApplicableCompleted

Evaluation of the Valsalva Assist Device to Treat SVT

Showing all 3 trials

Research Network

Common Treatments

  • Supine Vm Vad1
  • Valsalva Assist Device Vad1
  • Modified Vm Manonmeter1
  • Standard Care1
  • Supine Vad Manometer1

Active Sponsors

  • Royal Devon and Exeter NHS Foundation Trust2
  • Academic Health Science Centres1
  • South Western Ambulance Service NHS Foundation Trust1
  • University of Exeter1
  • Duzce University1

Top Investigators

Related Conditions

  • Svt2
  • Adverse Cardiac Event1
  • Tonsillitis Hypertrophic1
  • Adenotonsillar Hypertrophy1
  • Emergencies1

Activity Timeline